Familial Alzheimer's is the rare inherited form that runs directly from parent to child. It passes down when a parent contributes an altered copy of APP, PSEN1, or PSEN2, and one copy is enough to cause disease.
Each child of a carrier parent has a 50/50 chance of inheriting that altered copy. A child who inherits the change faces near-certain disease, approaching 99% penetrance. Symptoms usually start before age 65, often between 30 and 60, with a similar early age across generations.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Which genes cause it and what do they do?
- What does a 50/50 chance mean in practice?
- When do symptoms begin and how rare is this form?
- How is this different from APOE risk and Down syndrome?
Which genes cause it and what do they do?
Three genes cause this form: APP on chromosome 21, PSEN1 on chromosome 14, and PSEN2 on chromosome 1. These variants alter how the brain processes amyloid, according to the Alzheimer's Association genetic testing statement. A change in any one of the three can set the disease process in motion.
PSEN1 and PSEN2 provide parts of gamma-secretase, an enzyme complex that cuts APP. When those parts are altered, amyloid-beta handling breaks down and plaques build up. Plaque buildup is a central brain change in Alzheimer's.
What does a 50/50 chance mean in practice?
Inheritance is autosomal-dominant, which means one altered copy from either parent is enough. The other typical copy cannot cancel it out. The sex of the parent or child does not change the odds.
A child who inherits the variant faces near-certain disease, approaching 99% penetrance, according to the Cure Alzheimer's Fund genetics guide. That makes predictive testing and family planning unusually weighty. A genetics clinic can explain testing choices, privacy protections, and support options.
- one carrier parent gives each pregnancy the same 50/50 chance
- siblings can have different outcomes, so one may inherit it while another does not
- a child who does not inherit the variant does not carry it forward
When do symptoms begin and how rare is this form?
Carriers typically develop symptoms early, usually before age 65 and often between ages 30 and 60. Families often see a consistent early pattern, with parents, aunts, uncles, and siblings affected at roughly similar ages. A sharp drop in onset age is not required for concern, but repeated early onset deserves attention.
This deterministic form is rare. It accounts for 1% or less of all Alzheimer's cases. It also accounts for only 10-15% of familial early-onset cases with dominant transmission, so most families with later or mixed ages do not fit this pattern.
How is this different from APOE risk and Down syndrome?
APOE-e4 on chromosome 19 is only a risk factor for late-onset disease, not a determinant. One copy doubles or triples risk and two copies raise risk 8-12-fold without guaranteeing disease, according to the Mayo Clinic gene guide. Many carriers never develop dementia, and many patients never carry APOE-e4.
Down syndrome involves an extra chromosome 21 with an extra APP copy. That extra copy gives sharply higher early Alzheimer's risk, the National Institute on Aging reports. This form is not parent-to-child inherited in the same way. Write down each relative's age at first symptoms and bring that record to a genetics appointment.





